首页> 外文期刊>药学学报:英文版 >Regulation of drug metabolism and toxicity by multiple factors of genetics,epigenetics,lncRNAs,gut microbiota,and diseases:a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations(MDO)
【24h】

Regulation of drug metabolism and toxicity by multiple factors of genetics,epigenetics,lncRNAs,gut microbiota,and diseases:a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations(MDO)

机译:遗传,表观遗传学,lncRNA,肠道菌群和疾病等多种因素对药物代谢和毒性的调节:第21届国际微粒体与药物氧化研讨会(MDO)会议报告

摘要

Variations in drug metabolism may alter drug efficacy and cause toxicity;better understanding of the mechanisms and risks shall help to practice precision medicine.At the 21 st International Symposium on Microsomes and Drug Oxidations held in Davis,California,USA,in October 2-6,2016,a number of speakers reported some new findings and ongoing studies on the regulation mechanisms behind variable drug metabolism and toxicity,and discussed potential implications to personalized medications.A considerably insightful overview was provided on genetic and epigenetic regulation of gene expression involved in drug absorption,distribution,metabolism,and excretion(ADME) and drug response.Altered drug metabolism and disposition as well as molecular mechanisms among diseased and special populations were presented.In addition,the roles of gut microbiota in drug metabolism and toxicology as well as long non-coding RNAs in liver functions and diseases were discussed.These findings may offer new insights into improved understanding of ADME regulatory mechanisms and advance drug metabolism research.
机译:药物代谢的变化可能会改变药物的疗效并引起毒性;对机制和风险的更好理解将有助于实践精密医学。10月2日至6日在美国加利福尼亚州戴维斯举行的第21届国际微粒体和药物氧化国际研讨会上,2016年,许多发言者报告了有关可变药物代谢和毒性背后的调控机制的一些新发现和正在进行的研究,并讨论了对个性化药物的潜在影响。对涉及药物的基因表达的遗传和表观遗传学调控提供了相当有见地的概述吸收,分布,代谢和排泄(ADME)以及药物反应讨论了肝功能和疾病中的非编码RNA。这些发现可能会提供新的见解增进对ADME调控机制的了解并推进药物代谢研究。

著录项

  • 来源
    《药学学报:英文版》 |2017年第2期|P.241-248|共8页
  • 作者单位

    Department of Biochemistry and Molecular Medicine,School of Medicine,University of California at Davis;

    Department of Physiology and Pharmacology,Karolinska Institutet;

    Department of Pharmaceutical Sciences,College of Pharmacy,University of Arizona;

    Department of Pharmacology and Toxicology,School of Pharmacy,Rutgers University;

    Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology;

    Eberhard Karls University;

    Center of Pharmacogenomics and Department of Pharmaceutical Sciences,School of Pharmacy,University of Pittsburgh;

    Department of Pharmacy Practice,School of Pharmacy,University of Illinois at Chicago;

    Department of Pharmacology,School of Medicine,Emory University;

    Department of Microbiology and Immunology and the George William Hooper Research Foundation,University of California at San Francisco;

    Department of Environmental and Occupational Health Sciences,University of Washington;

    Department of Chemistry,University of North Carolina at Chapel Hill;

    Department of Biology and Bioinformatics Program,Boston University;

    Department of Physiology and Neurobiology,University of Connecticut;

    Department of Pharmaceutical Sciences,School of Pharmacy,University of Connecticut;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类
  • 关键词

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号